No significant relationship has been identified between HPV positivity and KRAS mutations despite an examination of the association between these two markers.43 The KRAS G12D mutation appears to hinder an effective immune response against tumors.44 Numerous trials, both in preclinical and clinical settings, have sought therapeutic options for KRAS-mutated patients with colorectal cancer. The gene discussed is KRAS; the disease is colorectal cancer.